Median Technologies Reports Its Business Activity for the Fi

H1 2023 revenue at €11.4M, an increase from H2 2022 revenue (€11.1M).Order backlog at €64.6M as at June 30, 2023, +€2.6M compared to March 31, 2023, +€3.8M compared to December 31, 2022.Onboarding of academic sites involved in the pivotal validation plan in progress for the iBiopsy® LCS CADe/CADx software as medical...

Related Keywords

Shanghai , China , France , Paris , France General , French , Lcs Cade Cadx , Caroline Carmagnol , Emmanuelle Leygues , Celestial Successor Fund , Progress Of The Company , Head Of Corporate Marketing Financial Communications , Lcs Cae Cadx Software As Medical Device , Imaging Contract Research Organization , Bonds , Lcs Cade Cadx Software As Medical Device , Regulatory News , Euronext Growth , Fredrik Brag , Median Technologies , Medical Device , Lung Cancer Screening , Multi Reader Case , Median Technologie , Securities Purchase Agreement , Convertible Bonds , European Investment , General Regulation , French Autorit , Des March , Artificial Intelligence , Contract Research Organization , Corporate Marketing , Financial Communications ,